Center Hospital of the National Center for Global Health and Medicine

Shinjyuku-ku, Tokyo 162-8655

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling